Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Protara Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +3 vs. Q3 2021
- Shares held
- 6.87M
- +597.3K (+9.5%) vs. Q3 2021
- Total value
- $46.5M
- +$3.07M (+7.1%) vs. Q3 2021
- New holders
- 7
- 13 more added
- Sold out
- 4
- 11 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| American Portfolios Advisors | 100 | $675 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 174 | $1.00K | 0.00% | −2,426−93.3% | Reduced |
| Royal Bank of Canada | 159 | $1.00K | 0.00% | −505−76.1% | Reduced |
| Federated Hermes, Inc. | 130 | $1.00K | 0.00% | +130 | New |
| Simplex Trading, LLC | 575 | $3.00K | 0.00% | −6−1.0% | Reduced |
| Wells Fargo & Company | 560 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 799 | $6.00K | 0.00% | +799 | New |
| JPMorgan Chase & Co | 1,103 | $7.00K | 0.00% | −6,937−86.3% | Reduced |
| Bank of America Corp | 6,878 | $47.0K | 0.00% | +6,356+1,217.6% | Added |
| Gyon Technologies Capital Management, LP | 12,553 | $85.0K | 0.02% | +12,553 | New |
| Trexquant Investment LP | 15,155 | $102.0K | 0.01% | +2,701+21.7% | Added |
| Prelude Capital Management, LLC | 16,855 | $114.0K | 0.01% | +3,700+28.1% | Added |
| Acadian Asset Management LLC | 17,219 | $115.0K | 0.00% | +17,219 | New |
| Bank of New York Mellon Corp | 17,907 | $120.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 22,215 | $150.0K | 0.00% | −64−0.3% | Reduced |
| Boothbay Fund Management, LLC | 27,591 | $186.0K | 0.01% | −19,832−41.8% | Reduced |
| Morgan Stanley | 27,900 | $188.0K | 0.00% | +1,318+5.0% | Added |
| Susquehanna International Group, LLP | 27,862 | $188.0K | 0.00% | +11,969+75.3% | Added |
| Sender Co & Partners, Inc. | 28,502 | $192.0K | 0.12% | +28,502 | New |
| State Street Corp | 29,800 | $201.0K | 0.00% | +7,000+30.7% | Added |
| Dimensional Fund Advisors LP | 33,474 | $226.0K | 0.00% | +33,474 | New |
| BlackRock Inc. | 40,140 | $271.0K | 0.00% | −3,896−8.8% | Reduced |
| Bridgeway Capital Management, LLC | 53,500 | $361.0K | 0.01% | −59,000−52.4% | Reduced |
| Renaissance Technologies LLC | 64,800 | $437.0K | 0.00% | −51,100−44.1% | Reduced |
| Geode Capital Management, LLC | 79,017 | $533.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 106,245 | $717.0K | 0.00% | +1,327+1.3% | Added |
| Two Sigma Advisers, LP | 170,918 | $1.15M | 0.00% | +2,100+1.2% | Added |
| Two Sigma Investments, LP | 190,278 | $1.28M | 0.00% | +59,343+45.3% | Added |
| Goldman Sachs Group Inc | 197,302 | $1.33M | 0.00% | +41,329+26.5% | Added |
| Baker Bros. Advisors LP | 199,671 | $1.35M | 0.01% | 00.0% | Unchanged |
| Boxer Capital, LLC | 209,227 | $1.41M | 0.06% | 00.0% | Unchanged |
| DLD Asset Management, LP | 229,231 | $1.55M | 0.13% | +229,231 | New |
| Ikarian Capital, LLC | 279,256 | $1.89M | 0.54% | −200,739−41.8% | Reduced |
| Perceptive Advisors LLC | 421,641 | $2.85M | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 428,366 | $2.89M | 0.00% | +81,935+23.7% | Added |
| Vanguard Group Inc | 435,251 | $2.94M | 0.00% | −562−0.1% | Reduced |
| OrbiMed Advisors LLC | 830,641 | $5.61M | 0.07% | +380,641+84.6% | Added |
| Opaleye Management Inc. | 2,650,000 | $18.0M | 3.82% | +91,528+3.6% | Added |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,955−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,130−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −15,190−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Knott David M | – | – | – | – | Not filed |